MPN Podcast Pilot Study

NCT03907774 | Completed

• 1 other identifier: STUDY00008403
• Study Type: observational
• Target: 39
• Locations: 1 country
• Sites: 1

Brief Summary

Enrolled MPN patients will participate in a podcast intervention via a smartphone app. They will listen to 60 minutes per week of podcasts through this app, which consist of cancer-related health education material. Participants have the option to listen to additional podcasts beyond the 60-minute weekly prescription if they desire. Participation will be tracked through self-report logs. In addition, questionnaires will be administered at baseline, midpoint (week 6), and post-intervention (week 12), which ask about demographics, health information, and satisfaction. The hypothesis is that the smartphone app is feasible for delivering home-based health education podcasts to MPN patients.

Conditions

Myeloproliferative Neoplasm, Unclassifiable

Outcome Measures

Primary Outcomes (3)

• Acceptability of Podcast App: satisfaction survey

  Acceptability will be measured with a satisfaction survey. Benchmarks for acceptability include greater than or equal to 70% response to the following questions in the survey: 1) satisfaction with the app's content, 2) intending to continue using the app, 3) enjoying using the apps, and 4) recommending it to other MPN patients. The % of participants indicating responses to the four prior questions will be considered "acceptable" if all four questions are responded to with a greater than or equal to 70% response rate.

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Demand of Podcast App

  Demand will be measured using adherence to the podcast prescription. Podcast viewing will be tracked by the smartphone app developers and reported to the Principal Investigator. Adherence benchmarks are defined as an average of greater than or equal to 49 minutes per week of podcast viewing across all participants (i.e., greater than or equal to 70% of prescribed podcasts).

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Practicality of Podcast App: participation rate

  Practicality will be measured through a participation rate greater than or equal to 70%, with completion being defined as completing all three self-report questionnaires.

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

Secondary Outcomes (8)

• MPN Total Symptom Burden (severity and symptomology)

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Fatigue

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Anxiety

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Depression

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

• Sleep Disturbance

  Change from baseline to mid-point (week 6) and post-intervention (week 12)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The group will be compiled of eligible participants recruited through physicians, social media, and other online-based recruitment strategies.

You may qualify if:

• Have a diagnosis of essential thrombocythemia, polycythemia vera, or myelofibrosis identified by treating physician
• Have access to a smartphone on a regular basis
• Have access to reliable home internet
• Read and understand English
• years or older

You may not qualify if:

• Any planned change in pharmacologic intervention (i.e., new drug, bone marrow transplant) during the study interval (i.e., 12 weeks)

Sponsors & Collaborators

• Arizona State University: lead

Study Sites (1)

Arizona State University

Phoenix, Arizona, 85004, United States

Location

Related Publications (1)

• Huberty J, Eckert R, Puzia M, Laird B, Larkey L, Mesa R. A Novel Educational Control Group Mobile App for Meditation Interventions: Single-Group Feasibility Trial. JMIR Form Res. 2020 Jul 21;4(7):e19364. doi: 10.2196/19364.

  PMID: 32706719 DERIVED

MeSH Terms

Conditions

Myeloproliferative Disorders

Condition Hierarchy (Ancestors)

Bone Marrow Diseases; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Officials

• Jennifer Huberty, PhD

  Arizona State University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 5, 2019
• First Posted: April 9, 2019
• Study Start: June 1, 2019
• Primary Completion: November 24, 2019
• Study Completion: November 24, 2019
• Last Updated: March 27, 2020

Record last verified: 2020-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)